Chung‐Pin Li

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

Medicine, Oncology, Pharmacology +16

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

Eric Van Cutsem, Margaret A. Tempero, Darren Sigal et al. · Journal of Clinical Oncology · 2020 · 446 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas

Jeffrey R. Infante, Bradley G. Somer, Joon Oh Park et al. · European Journal of Cancer · 2014 · 363 citations

Medicine, Oncology, Pharmacology +15

Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study

Chung‐Pin Li, Yee Chao, Kwan‐Hwa Chi et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 210 citations

Medicine, Oncology, Radiation Oncology +13

High Blood Pressure and All-Cause and Cardiovascular Disease Mortalities in Community-Dwelling Older Adults

Chen‐Yi Wu, Hsiao‐Yun Hu, Yiing‐Jenq Chou et al. · Medicine · 2015 · 208 citations · Full text

Medicine, Geriatric Medicine, Aging +16